Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 44.76 M43.37 M44.43 M71.34 M28 M26.56 M 170.31 M Research & development —————— — Operating income 16.65 M19.98 M17.69 M19.83 M24.85 M31.17 M 93.54 M Non-Operating Income, Total —1.6 M———— — Interest expense, net of interest capitalized 540 K540 K541 K702 K664 K642 K 2.55 M Non-Operating Income, excl. Interest Expenses —1.06 M———— — Unusual income/expense —————— — Pretax income 9.26 M12.62 M10.19 M12.65 M18.16 M24.91 M 65.91 M Equity in earnings —————— — Taxes 2.46 M2.91 M3.1 M1.62 M4.36 M6.16 M 15.24 M Non-controlling/minority interest —————— — After tax other income/expense 759 K3.23 M3.12 M-731 K2.51 M227 K 5.12 M Net income before discontinued operations 6.6 M9.71 M7.09 M11.33 M13.8 M18.75 M 50.97 M Discontinued operations 207 K———-15.63 M1.28 M — Net income 6.8 M9.71 M7.09 M11.33 M-1.83 M20.03 M 36.62 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 6.8 M9.71 M7.09 M11.33 M-1.83 M20.03 M 36.62 M Basic earnings per share (Basic EPS) 0.180.260.190.3-0.050.53 0.97 Diluted earnings per share (Diluted EPS) 0.180.260.190.3-0.050.53 0.97 Average basic shares outstanding 37.3 M37.39 M37.39 M37.37 M37.41 M37.55 M — Diluted shares outstanding 37.41 M37.41 M37.58 M37.56 M37.71 M37.79 M — EBITDA 40.69 M24.43 M20.98 M16.15 M37.73 M43.91 M 118.77 M EBIT 26.95 M19.98 M16.66 M11.93 M24.6 M30.91 M 84.1 M Cost of revenue 137.67 M138.92 M136.87 M136.23 M108.03 M117.74 M 498.87 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 4.46 M4.45 M4.32 M4.22 M13.13 M13.01 M 34.67 M